![John A. Lambert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John A. Lambert
Presidente en ImmunoBiology Ltd. .
Perfil
John A.
Lambert currently holds the position of Executive Chairman at ImmunoBiology Ltd.
He also holds the position of Executive Director at Powderject Pharmaceuticals Plc.
Additionally, he is the Director of JG Solutions Ltd.
In the past, he served as Non-Executive Chairman at Cambridge Biostability Ltd.
and Chairman at Farmaprojects SA. He was also Chairman-Supervisory Board at Mucosis BV and Hookipa Biotech AG.
He served as Director at Novavax, Inc. and Acambis Plc.
He was the President of Seqirus Vaccines Ltd.
and Sanofi Pasteur, Inc. Furthermore, he was the President of European Vaccine Manufacturers.
Cargos activos de John A. Lambert
Empresas | Cargo | Inicio |
---|---|---|
JG Solutions Ltd. | Director/Miembro de la Junta | - |
ImmunoBiology Ltd.
![]() ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Presidente | - |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Director/Miembro de la Junta | 08/07/2003 |
Antiguos cargos conocidos de John A. Lambert.
Empresas | Cargo | Fin |
---|---|---|
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Presidente | 18/10/2017 |
NOVAVAX, INC. | Presidente | 17/02/2010 |
Cambridge Biostability Ltd.
![]() Cambridge Biostability Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Biostability Ltd. manufactures vaccines and drugs. The firm's two platforms VitRIS and HydRIS offers pharmaceuticals, vaccines, and other biological products in thermo-stable, instantly-injectable formats. The company was founded by Dr Bruce Roser in 2003 and is headquartered in UK. | Presidente | 16/06/2010 |
Farmaprojects SA
![]() Farmaprojects SA Pharmaceuticals: MajorHealth Technology Farmaprojects SA provides regulatory affairs services to third party companies. The company was founded in 1988 and is headquartered in Barcelona, Spain. | Presidente | 01/03/2009 |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Director/Miembro de la Junta | 01/09/2008 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Empresas privadas | 12 |
---|---|
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Seqirus Vaccines Ltd.
![]() Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Sanofi Pasteur, Inc.
![]() Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Cambridge Biostability Ltd.
![]() Cambridge Biostability Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Biostability Ltd. manufactures vaccines and drugs. The firm's two platforms VitRIS and HydRIS offers pharmaceuticals, vaccines, and other biological products in thermo-stable, instantly-injectable formats. The company was founded by Dr Bruce Roser in 2003 and is headquartered in UK. | Health Technology |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
Farmaprojects SA
![]() Farmaprojects SA Pharmaceuticals: MajorHealth Technology Farmaprojects SA provides regulatory affairs services to third party companies. The company was founded in 1988 and is headquartered in Barcelona, Spain. | Health Technology |
European Vaccine Manufacturers | |
GAVI Alliance (United States) | Miscellaneous |
Mucosis BV
![]() Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |
ImmunoBiology Ltd.
![]() ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
JG Solutions Ltd. | |
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
- Bolsa de valores
- Insiders
- John A. Lambert